Breast Cancer In Young Women
Programs Breast Cancer In Young Women Breast Cancer In Young Women Get Involved Partners And Sponsors Community Donate
Clinical Trials
Participating in clinical trials is one of the most meaningful actions we, as members of this community of young women, can take to help each other. Working together with medical researchers, we have the power to ensure good data that’s relevant to us all—while answering those questions that continue to confound young women and doctors alike.
More than Numbers, But Young Women Better Be Counted
By participating, you’ll join the ranks of numerous YSC constituents already playing a vital role in breast-cancer research. Personally, depending on the stage of the trial you join, your own fight against cancer might get a boost from new treatments—long before they become standard. Read more about the benefits of participation here.
RSS: Breast Cancer in Young Women Clinical Trials
Studies found on ClinicalTrials.gov by a search of: breast cancer young women | updated in the last 30 days
The Immune System's Response to Young Women's Breast Cancer
Conditions: Breast Cancer; Breast Cancer and PregnancyIntervention:
Sponsors: University of Colorado, Denver; University of Colorado, Denver
Recruiting - verified May 2013
Thu, 29 Dec 2011 12:00:00 EST
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
Condition: Breast CancerIntervention: Genetic: ONCOTYPEDX Test
Sponsors: Ontario Clinical Oncology Group (OCOG); Ontario Clinical Oncology Group (OCOG); Ontario Ministry of Health and Long Term Care
Recruiting - verified May 2013
Wed, 24 Aug 2011 12:00:00 EDT
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIC Breast CancerInterventions: Drug: doxorubicin hydrochloride; Drug: docetaxel; Drug: cyclophosphamide; Biological: trastuzumab; Drug: paclitaxel; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified May 2013
Tue, 11 Jan 2011 12:00:00 EST
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV MelanomaInterventions: Biological: ipilimumab; Biological: recombinant interferon alfa-2b; Other: pharmacological study; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified April 2013
Sat, 08 Jan 2011 12:00:00 EST
Breastfeeding Support Intervention in Jaundiced Infants
Conditions: Jaundice; BreastfeedingIntervention: Other: Lactation Consultant support
Sponsors: Children's Hospital of Eastern Ontario; Children's Hospital of Eastern Ontario; The Physicians' Services Incorporated Foundation
Completed - verified February 2010
Wed, 26 Aug 2009 12:00:00 EDT
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Prostate Cancer; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Urethral Cancer; Stage IV Bladder Cancer; Stage IV Prostate Cancer; Transitional Cell Carcinoma of the Bladder; Urethral Cancer Associated With Invasive Bladder CancerInterventions: Drug: gemcitabine hydrochloride; Drug: cisplatin; Other: placebo; Biological: bevacizumab; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified May 2013
Fri, 17 Jul 2009 12:00:00 EDT
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
Condition: Breast CancerIntervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Active, not recruiting - verified May 2013
Fri, 06 Mar 2009 12:00:00 EST
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
Condition: InfertilityInterventions: Other: Biology and ultrasonography after chemotherapy; Other: Biology and ultrasonography after chemotherapy; Other: Biology and ultrasonography after chemotherapy
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Terminated - verified May 2013
Wed, 02 Jul 2008 12:00:00 EDT
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Conditions: Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung CancerInterventions: Drug: sunitinib malate; Other: placebo; Procedure: quality-of-life assessment; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Recruiting - verified May 2013
Fri, 06 Jun 2008 12:00:00 EDT
RSS: Breast Cancer Clinical Trials
Studies found on ClinicalTrials.gov by a search of: Breast Cancer | updated in the last 30 days
Breast Cancer Molecular Analysis Protocol
Condition: Metastatic Breast CancerIntervention: Procedure: Core Biopsy
Sponsors: Yale University; Yale University; Foundation Medicine
Recruiting - verified May 2013
Mon, 13 May 2013 12:00:00 EDT
Enhancing Exercise in Breast Cancer Survivors
Condition: Breast CancerInterventions: Behavioral: Newsletter about physical activity and breast cancer survivors; Behavioral: Changing your habits brochure; Behavioral: Tips for making exercise enjoyable and personally-valued; Behavioral: Testimonials from breast cancer survivors
Sponsors: Duke University; Duke University
Not yet recruiting - verified May 2013
Mon, 06 May 2013 12:00:00 EDT
Breast Cancer Risk Reduction: A Patient Doctor Intervention
Condition: Breast CancerIntervention: Other: BreastCARE
Sponsors: University of California, San Francisco; University of California, San Francisco; Susan G. Komen Breast Cancer Foundation; California Breast Cancer Research Program
Active, not recruiting - verified May 2013
Wed, 10 Apr 2013 12:00:00 EDT
Cluster Randomized Trial Comparing Interventions to Enhance Genetic Counseling Among Breast Cancer Patients
Condition: Breast CancerIntervention: Other: Active Genetic Counseling Provider Intervention
Sponsors: University of South Florida; University of South Florida; National Cancer Institute (NCI)
Not yet recruiting - verified January 2013
Thu, 07 Feb 2013 12:00:00 EST
An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya
Condition: Breast CancerIntervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2013
Mon, 19 Sep 2011 12:00:00 EDT
Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
Conditions: Tubular Breast Cancer Stage II; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; Tubular Breast Cancer Stage III; HER-2 Positive Breast Cancer; Inflammatory Breast Cancer Stage IV; Inflammatory Breast CancerInterventions: Drug: Carboplatin; Drug: background treatment according to standards fpr triple negative and Her2pos breast cancer patients
Sponsors: German Breast Group; German Breast Group; TEVA; Roche Pharma AG; GlaxoSmithKline
Active, not recruiting - verified May 2013
Wed, 17 Aug 2011 12:00:00 EDT
ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
Conditions: Breast Cancer; Metastatic Breast Cancer; BRCA1 or BRCA2 Associated Breast CancerInterventions: Drug: ABT-888; Drug: temozolomide
Sponsors: Massachusetts General Hospital; Steven Isakoff, MD, PhD; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Abbott
Active, not recruiting - verified April 2013
Thu, 05 Nov 2009 12:00:00 EST
Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
Condition: Breast CancerInterventions: Other: flow cytometry; Other: fluorescence activated cell sorting; Other: immunohistochemistry staining method; Other: immunologic technique; Other: biomarker analysis
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified May 2013
Sat, 09 May 2009 12:00:00 EDT
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Conditions: Breast Cancer; Fatigue; HypothyroidismInterventions: Other: physiologic testing; Procedure: fatigue assessment and management; Procedure: management of therapy complications
Sponsors: University of South Florida; University of South Florida; National Cancer Institute (NCI)
Active, not recruiting - verified September 2010
Thu, 08 Jun 2006 12:00:00 EDT
Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Condition: Breast CancerIntervention: Drug: exemestane
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group; Grupo Espanol de Investigacion del Cancer de Mama; UNICANCER
Active, not recruiting - verified May 2013
Fri, 14 May 2004 12:00:00 EDT
Post-Treatment Navigator
View, download or orderInfo Just for you
Newly Diagnosed
Resource Kit
